• Je něco špatně v tomto záznamu ?

Novel methods of treating ovarian infertility in older and POF women, testicular infertility, and other human functional diseases

A. Bukovsky,

. 2015 ; 13 (-) : 10. [pub] 20150225

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu úvodníky, úvodní články

Perzistentní odkaz   https://www.medvik.cz/link/bmc16020868

In vitro maturation (IVM) and in vitro fertilization (IVF) technologies are facing with growing demands of older women to conceive. Although ovarian stem cells (OSCs) of older women are capable of producing in vitro fresh oocyte-like cells (OLCs), such cells cannot respond to IVM and IVF due to the lack of granulosa cells required for their maturation. Follicular renewal is also dependent on support of circulating blood mononuclear cells. They induce intermediary stages of meiosis (metaphase I chromosomal duplication and crossover, anaphase, telophase, and cytokinesis) in newly emerging ovarian germ cells, as for the first time demonstrated here, induce formation of granulosa cells, and stimulate follicular growth and development. A pretreatment of OSC culture with mononuclear cells collected from blood of a young healthy fertile woman may cause differentiation of bipotential OSCs into both developing germ and granulosa cells. A small blood volume replacement may enable treatment of ovarian infertility in vivo. The transferred mononuclear cells may temporarily rejuvenate virtually all tissues, including improvement of the function of endocrine tissues. Formation of new follicles and their development may be sufficient for IVM and IVF. The novel proposed in vitro approaches may be used as a second possibility. Infertility of human males affects almost a half of the infertility cases worldwide. Small blood volume replacement from young healthy fertile men may also be easy approach for the improvement of sperm quality in older or other affected men. In addition, body rejuvenation by small blood volume replacement from young healthy individuals of the same sex could represent a decline of in vitro methodology in favor of in vivo treatment for human functional diseases. Here we propose for the first time that blood mononuclear cells are essential for rejuvenation of those tissues, where immune system components participate in an appropriate division and differentiation of tissue stem cells. If needed, small blood volume replacement from distinct young healthy individuals could be utilized in six month intervals for repair of young altered or aged reproductive and other tissue functions. Systemic and local use of honey bee propolis tincture is an alternative option for functional rejuvenation of some tissues.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16020868
003      
CZ-PrNML
005      
20160804122411.0
007      
ta
008      
160722s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12958-015-0001-8 $2 doi
024    7_
$a 10.1186/s12958-015-0001-8 $2 doi
035    __
$a (PubMed)25889983
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Bukovsky, Antonin $u The Institute of Biotechnology, Academy of Sciences of the Czech Republic, Prague, Czech Republic. a_buko@comcast.net.
245    10
$a Novel methods of treating ovarian infertility in older and POF women, testicular infertility, and other human functional diseases / $c A. Bukovsky,
520    9_
$a In vitro maturation (IVM) and in vitro fertilization (IVF) technologies are facing with growing demands of older women to conceive. Although ovarian stem cells (OSCs) of older women are capable of producing in vitro fresh oocyte-like cells (OLCs), such cells cannot respond to IVM and IVF due to the lack of granulosa cells required for their maturation. Follicular renewal is also dependent on support of circulating blood mononuclear cells. They induce intermediary stages of meiosis (metaphase I chromosomal duplication and crossover, anaphase, telophase, and cytokinesis) in newly emerging ovarian germ cells, as for the first time demonstrated here, induce formation of granulosa cells, and stimulate follicular growth and development. A pretreatment of OSC culture with mononuclear cells collected from blood of a young healthy fertile woman may cause differentiation of bipotential OSCs into both developing germ and granulosa cells. A small blood volume replacement may enable treatment of ovarian infertility in vivo. The transferred mononuclear cells may temporarily rejuvenate virtually all tissues, including improvement of the function of endocrine tissues. Formation of new follicles and their development may be sufficient for IVM and IVF. The novel proposed in vitro approaches may be used as a second possibility. Infertility of human males affects almost a half of the infertility cases worldwide. Small blood volume replacement from young healthy fertile men may also be easy approach for the improvement of sperm quality in older or other affected men. In addition, body rejuvenation by small blood volume replacement from young healthy individuals of the same sex could represent a decline of in vitro methodology in favor of in vivo treatment for human functional diseases. Here we propose for the first time that blood mononuclear cells are essential for rejuvenation of those tissues, where immune system components participate in an appropriate division and differentiation of tissue stem cells. If needed, small blood volume replacement from distinct young healthy individuals could be utilized in six month intervals for repair of young altered or aged reproductive and other tissue functions. Systemic and local use of honey bee propolis tincture is an alternative option for functional rejuvenation of some tissues.
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fertilizace in vitro $x metody $x trendy $7 D005307
650    _2
$a zárodečné buňky $x cytologie $7 D005854
650    _2
$a lidé $7 D006801
650    _2
$a ženská infertilita $x terapie $7 D007247
650    _2
$a mužská infertilita $x terapie $7 D007248
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ovarium $x cytologie $7 D010053
650    _2
$a primární ovariální insuficience $x komplikace $7 D016649
650    _2
$a kmenové buňky $x cytologie $7 D013234
650    _2
$a testis $x cytologie $7 D013737
655    _2
$a úvodníky $7 D016421
655    _2
$a úvodní články $7 D054711
773    0_
$w MED00008251 $t Reproductive biology and endocrinology RB&E $x 1477-7827 $g Roč. 13, č. - (2015), s. 10
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25889983 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160722 $b ABA008
991    __
$a 20160804122642 $b ABA008
999    __
$a ok $b bmc $g 1155538 $s 945396
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 13 $c - $d 10 $e 20150225 $i 1477-7827 $m Reproductive biology and endocrinology $n Reprod Biol Endocrinol $x MED00008251
LZP    __
$a Pubmed-20160722

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...